Summarised unaudited interim results for the six months ended 31 December 2022 AfroCentric Investment Corporation Limited (Incorporated in the Republic of South Africa) (Registration number 1988/000570/06) JSE Code: ACT ISIN: ZAE000078416 (“the Company" or AfroCentric”) Summarised unaudited interim results for the six months ended 31 December 2022 Introduction to the AfroCentric Group AfroCentric is a Level 1, majority black-owned JSE Limited listed investment holding company, which owns and operates a diverse range of healthcare-related enterprises that provide specialised medical scheme administration and deliver a range of healthcare products and services to the public and private healthcare sectors. The principal objective of the Group is to ensure the delivery of efficient health management services and the distribution of quality products - all at a manageable and affordable cost for the benefit of our stakeholders. AfroCentric has successfully broadened its interests in the industry by continuing to pursue new opportunities to expand and rationalise its presence across the healthcare sector. The Board presents a summary of the Company’s results for the six months ended 31 December 2022. Salient Features % Unaudited six Unaudited six change months ended months ended 31 December 31 December 2022 2021 Total revenue from contracts with customers (R’ 1.2 4 322.1 4 269.6 million) Profit before tax (R’ million) (17.2) 270.9 327.3 Profit for the year (R’ million) (16.9) 194.4 233.6 Basic earnings (R’ million) (18.5) 125.8 154.3 Headline earnings (R’ million) (18.7) 125.7 154.5 Basic earnings (cents per share) (18.8) 21.79 26.83 Headline earnings (cents per share) (19.0) 21.76 26.86 Weighted average number of ordinary shares 577.4 million 575.1 million Dividend declared (cents per share) (100.0) 0 17 Dividends The Board has decided to follow a prudent approach to short term cash flow funding by postponing the interim dividend due to the significant increase in the trade receivables. A final full year dividend will be considered at year end in accordance with the Board’s assessment of the Group’s solvency and liquidity at that point in time. Full Announcement This short-form announcement is the responsibility of the Directors of the Company and is a summary of the information in the full announcement and does not contain full or complete details. The full announcement is available for viewing on the following websites: Company’s website: http://www.afrocentric.za.com/inv-reporting.php JSE website: https://senspdf.jse.co.za/documents/2023/JSE/ISSE/ACT/act2023.pdf Any investment decision by investors and/or shareholders should be based on consideration of the information contained in the full announcement released on SENS, copies of which are also available for inspection at the Company’s offices on workdays during business hours (at no charge) or on request from the company secretary by email: billym@afrocentrichealth.com Responsibility Statement The AfroCentric Board, individually and collectively, accepts responsibility for the information contained in this announcement insofar as it relates to AfroCentric. In addition, the AfroCentric Board confirms that, to the best of its knowledge and belief, the information contained in this announcement, as it relates to AfroCentric, is true and correct and, where appropriate, does not omit anything that is likely to affect the importance of the information contained herein pertaining to AfroCentric and that all reasonable enquiries to ascertain such information have been made. On behalf of the Board Dr ATM Mokgokong Mr A Banderker Chairperson Group Chief Executive Officer Johannesburg 13 September 2022 JSE Sponsor to AfroCentric Questco Corporate Advisory Proprietary Limited Date: 13-03-2023 09:36:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.